title: B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study.
authors.affiliation: University Medical Center, Groningen, The Netherlands. w.abdulahad@int.umcg.nl
authors.forename: W H
authors.initials: WH
authors.lastname: Abdulahad
authors.forename: J M
authors.initials: JM
authors.lastname: Meijer
authors.forename: F G M
authors.initials: FG
authors.lastname: Kroese
authors.forename: P M
authors.initials: PM
authors.lastname: Meiners
authors.forename: A
authors.initials: A
authors.lastname: Vissink
authors.forename: F K L
authors.initials: FK
authors.lastname: Spijkervet
authors.forename: C G M
authors.initials: CG
authors.lastname: Kallenberg
authors.forename: H
authors.initials: H
authors.lastname: Bootsma
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002452:Cell Count; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007072:Immunoglobulin D / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D013997:Time Factors; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000378:metabolism
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D007072:Immunoglobulin D; D007075:Immunoglobulin M; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; D000069283:Rituximab